by telrheum | Jun 25, 2024 | Psoriatic Arthritis, Interstitial Lung Disease, Rheumatoid Arthritis, Spondyloarthritis
Background and Purpose: Pulmonary issues are common yet often overlooked in people with rheumatic diseases like rheumatoid arthritis (RA), psoriatic arthritis (PsA), and peripheral spondyloarthritis (pSpA). These lung problems can lead to severe health consequences if...
by telrheum | Jun 25, 2024 | Hydroxychloroquine, Fatty Liver Disease, Rheumatoid Arthritis
Background: Rheumatoid arthritis (RA) is a chronic autoimmune disease that affects the joints and can lead to various other health issues. Previous research has indicated a high prevalence of non-alcoholic fatty liver disease (NAFLD) in RA patients. There’s a...
by telrheum | Jun 24, 2024 | Biologic Therapy, Anti-TNF, IL-23 Inhibitors, Il-6 inhibitors, JAK Inhibitor, Rituximab
Background: Rheumatoid arthritis (RA) patients often face higher cardiovascular risks due to chronic inflammation. Biologic disease-modifying antirheumatic drugs (biologic drugs) help control this inflammation, especially in those who don’t respond well to...
by telrheum | Jun 23, 2024 | Rheumatoid Arthritis, anti-CCP, Laboratory Testing
Background: The study aimed to determine if testing for anti-CCP3 antibodies in patients who are negative for anti-CCP2 antibodies but have musculoskeletal symptoms could better predict the progression to inflammatory arthritis (IA) or rheumatoid arthritis (RA)....
by telrheum | Jun 21, 2024 | Biologic Therapy, Anti-TNF, Spondyloarthritis
This study investigated why some children with juvenile spondyloarthritis (JSpA) do not respond to TNF inhibitors (TNFi), a common treatment. Researchers analyzed data from patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA)...
